BIOCHEMICAL SOCIETY TRANSACTIONS in these studies was found to average 23.06% a value significantly greater (P < 0.01) than that found for proinsulin (8.24%). The fractional excretion of the Al-B29 cross-linked insulin was 15.38%.
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Fuel homoeostasis after partial hepatectomy in the rat: effects of inhibition of fat oxidation by 2-tetradecylglycidate T. J. FRENCH,* A. W. GOODE,* P. S. SCHOFIELD? and M. C. SUGDENtS *Surgical Unit, The London Hospital, Whitechapel, London E l lBB, U.K., and ?Department of Chemical Pathology, The London Hospital Medical College, Turner Street, London El 2AD, U.K.
Randle et al. (1963, 1966) first suggested that the oxidation of fat fuels in preference to glucose conserved endogenous carbohydrate in starvation, and that excessive fat oxidation, through its restraint of glucose utilization and stimulation of gluconeogenesis, was partly responsible for the hyperglycaemia associated with diabetes mellitus. This concept stimulated the development of compounds acting to restrict fat oxidation, with a view to their therapeutic use to lower blood [glucose] in diabetes. Among these, 2-tetradecylglycidate (TDG) was shown to be a specific and effective hypoglycaemic drug in fasted or diabetic animals (Tutwiler et al., 1978) , thereby providing evidence for the operation of the glucose-fatty acid cycle. TDG inhibits carnitine palmitoyltransferase 1 (EC 2.3.1.21), thereby blocking mitochondria1 uptake and oxidation of long-chain acyl-CoA (Tutwiler & Dellevigne, 1979) . The operation of the glucose-fatty acid cycle requires that lipolysis responds to changes in carbohydrate supply, and that fat utilization rates are determined by nonesterified fatty acid (NEFA) availability. An important question is whether an increase in NEFA under conditions of adequate carbohydrate supply also limits glucose utilization. The present study used TDG to examine the possible importance of fat utilization for the maintenance of normoglycaemia in partially hepatectomized (PH) rats, where NEFA are elevated even if the rats are fed (Gove & Hems, 1978) . The results suggest a major role for NEFA oxidation in glucose homoeostasis immediately after partial hepatectomy.
Female Wistar rats (180-22Og) were fed ad libitum before two-thirds partial hepatectomy (Higgins & Anderson, 193 l) , or sham operation (SO). After surgery, rats were either fed ad libitum or starved for 24 h before Abbreviations used: TDG, 2-tetradecylglycidate; NEFA, nonesterified fatty acid; PH, partially hepatectomized; SO, sham operated.
$To whom correspondence should be addressed.
sampling. Rats were administered water (control) or TDG (2.5mg/100g body wt., suspension in 0.5%, w/v, carboxymethylcellulose) intragastrically (Tutwiler et al., 1979) and were killed 3 h later. Arterial blood samples were assayed for NEFA (plasma) and metabolites (KOH-neutralized HC10,-supernatants) by spectrophotometric methods (Williamson et al., 1962 , Slein, 1963 . Effects of TDG to increase plasma [NEFA] in starved rats have been attributed to inhibited NEFA utilization in the face of continued lipolysis (Tutwiler et al., 1978) . In the present experiments (Table l) , TDG increased NEFA to a similar extent in all the starved groups. Assuming that long-chain fatty acid oxidation is completely inhibited by TDG, the increase in NEFA estimates the extent to which NEFA are utilized in the control (no TDG) situation. Since NEFA accumulation in TDGtreated rats was unaffected by liver resection, it is implied that either NEFA utilization by the remnant liver or extrahepatic tissues is increased, or there is stringent feed-back control of the rate of lipolysis. TDG increased [NEFA] in fed PH rats at day 1 after surgery, suggesting significant utilization of long-chain fatty acids as substrates; NEFA accumulation over the 3 h period in the fed PH rats was approx. 40% of that observed if the rats were starved. TDG did not increase [NEFA] in any of the other fed groups.
Although 24 h starvation increased [NEFA] in both PH and SO groups, blood [ketone body] were not increased in starved PH rats at day 1 (Table 1) . Thus the rate of ketone body production by the liver remnant is < rates of ketone body utilization by extrahepatic tissues, possibly because of the decreased liver mass. The relatively increased plasma [NEFA] in fed PH rats at day 1 were also not associated with increased blood [ketone body]. TDG administration for 3 h resulted in low blood [ketone body], consistent with the rapid turnover of these substrates. Blood [glucose] were consistently lower in the PH rats (fed or starved, at 1 or 4 days after surgery) than in the SO controls (Table 1) . As expected, TDG decreased blood [glucose] in the starved groups. TDG also decreased [glucose] in fed PH rats at day 1, the first postoperative day, indicating that fat oxidation is required for the maintenance of blood [glucose] at this time. This may be related to a decrease in hepatic glycogen content (see 614th MEETING, OXFORD Table 1 . Effects of partial hepatectomy and 2-tetradecylglycidate on blood metabolite concentration in fed or 24 h-starved rats For details see the text. Liver weights at time of sampling (mean f s.E.M.) were as follows: (i) PH rats, day 1 fed, 1.51 f 0.14; day 1 starved, 1.28 f 0.05, day 4 fed, 2.61 f 0.18; day 4 starved, 2.46 f 0.07; (ii) SO rats -day 1 fed, 3.43 f 0.09; day 1 starved, 2.92 f 0.11; day 4 fed, 3.32 f 0.22; day 4 starved, 3.24 O.l5g/lOOg rat. Significant effects of PH are shown by: Q P < 0.05; §$P < 0.01; @$P < 0.001. Significant effects of TDG are shown by: *P < 0.05; **P < 0.01; ***P < 0.001. Significant effects of starvation are shown by: t P < 0.05; t t P < 0.01; tttP < 0.001. Gove & Hems, 1978) . In the present experiments glycogen concentration (mg/g wet wt.) and pool size (mg/l00 g rat) were 4 f 2 and 14 f 7 respectively in fed PH rats (n = 4) and 33 f 11 and 117 f 18 respectively in fed SO rats (n = 4). These findings indicate the potential importance of the operation of the glucose-fatty acid cycle, when liver mass is decreased and/or liver glycogen depleted.
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